目的评价踝关节镜下微骨折手术治疗距骨骨软骨损伤的疗效。方法回顾分析2005年7月至2012年8月瑞金医院骨科采用踝关节镜下微骨折方法治疗距骨骨软骨损伤的163例患者临床资料,其中男性79例,女性84例,年龄18～72（38.6±14.2）岁。分...目的评价踝关节镜下微骨折手术治疗距骨骨软骨损伤的疗效。方法回顾分析2005年7月至2012年8月瑞金医院骨科采用踝关节镜下微骨折方法治疗距骨骨软骨损伤的163例患者临床资料,其中男性79例,女性84例,年龄18～72（38.6±14.2）岁。分别采用疼痛视觉模拟评分（VAS）和美国足踝医师协会后足与踝关节评分（AOFAS HA score）对患者术前、术后12个月的疼痛情况和功能进行评价,部分患者在术后12个月随访时通过核磁共振影像对距骨软骨进行评价。结果 94例患者获得随访,随访时间（22.8±10.3）个月。VAS从术前的（4.51±0.84）分下降到术后的（0.98±0.90）分;AOFAS HA评分从术前的平均75分提高到术后的平均91分。25例患者记录了术后核磁共振影像,软骨修复情况均较术前影像有改善。结论踝关节镜下微骨折手术治疗距骨骨软骨损伤简单、安全,效果可靠、满意。展开更多
Osteochondral lesions of the talus(OLT) occur in up to 70% of acute ankle sprains and fractures. OLT have become increasingly recognized with the advancements in cartilage-sensitive diagnostic imaging modalities. Alth...Osteochondral lesions of the talus(OLT) occur in up to 70% of acute ankle sprains and fractures. OLT have become increasingly recognized with the advancements in cartilage-sensitive diagnostic imaging modalities. Although OLT may be treated nonoperatively, a number of surgical techniques have been described for patients whom surgery is indicated. Traditionally, treatment of symptomatic OLT have included either reparative procedures, such as bone marrow stimulation(BMS), or replacement procedures, such as autologous osteochondral transplantation(AOT). Reparative procedures are generally indicated for OLT < 150 mm^2 in area. Replacement strategies are used for large lesions or after failed primary repair procedures. Although shortand medium-term results have been reported, longterm studies on OLT treatment strategies are lacking. Biological augmentation including platelet-rich plasma and concentrated bone marrow aspirate is becoming increasingly popular for the treatment of OLT to enhance the biological environment during healing. In this review, we describe the most up-to-date clinical evidence of surgical outcomes, as well as both the mechanical and biological concerns associated with BMS and AOT. In addition, we will review the recent evidence for biological adjunct therapies that aim to improve outcomes and longevity of both BMS and AOT procedures.展开更多
文摘目的评价踝关节镜下微骨折手术治疗距骨骨软骨损伤的疗效。方法回顾分析2005年7月至2012年8月瑞金医院骨科采用踝关节镜下微骨折方法治疗距骨骨软骨损伤的163例患者临床资料,其中男性79例,女性84例,年龄18～72（38.6±14.2）岁。分别采用疼痛视觉模拟评分（VAS）和美国足踝医师协会后足与踝关节评分（AOFAS HA score）对患者术前、术后12个月的疼痛情况和功能进行评价,部分患者在术后12个月随访时通过核磁共振影像对距骨软骨进行评价。结果 94例患者获得随访,随访时间（22.8±10.3）个月。VAS从术前的（4.51±0.84）分下降到术后的（0.98±0.90）分;AOFAS HA评分从术前的平均75分提高到术后的平均91分。25例患者记录了术后核磁共振影像,软骨修复情况均较术前影像有改善。结论踝关节镜下微骨折手术治疗距骨骨软骨损伤简单、安全,效果可靠、满意。
文摘Osteochondral lesions of the talus(OLT) occur in up to 70% of acute ankle sprains and fractures. OLT have become increasingly recognized with the advancements in cartilage-sensitive diagnostic imaging modalities. Although OLT may be treated nonoperatively, a number of surgical techniques have been described for patients whom surgery is indicated. Traditionally, treatment of symptomatic OLT have included either reparative procedures, such as bone marrow stimulation(BMS), or replacement procedures, such as autologous osteochondral transplantation(AOT). Reparative procedures are generally indicated for OLT < 150 mm^2 in area. Replacement strategies are used for large lesions or after failed primary repair procedures. Although shortand medium-term results have been reported, longterm studies on OLT treatment strategies are lacking. Biological augmentation including platelet-rich plasma and concentrated bone marrow aspirate is becoming increasingly popular for the treatment of OLT to enhance the biological environment during healing. In this review, we describe the most up-to-date clinical evidence of surgical outcomes, as well as both the mechanical and biological concerns associated with BMS and AOT. In addition, we will review the recent evidence for biological adjunct therapies that aim to improve outcomes and longevity of both BMS and AOT procedures.
